immunovac
Allergenexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Sep 1, 2012 (NCT02787863)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Staphylococcus sp.Immunity, active
Staphylococcus sp. immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- immunovac
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02787863 | Phase 4 | Sep 1, 2012 | Institute of Sera and Vaccines RAS, Moscow, Pfizer, Russian Academy of Medical Sciences |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Institute of Sera and Vaccines RAS, Moscow | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Pfizer | For profit | 1 | 0 | 1 | 2012 |
| Russian Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2012 |
3 organizations
Page 1 / 1